Anthropic CEO Dario Amodei sat down with CBS News for an exclusive interview Friday, hours after Defense Secretary Pete ...
This transcript has been lightly edited for clarity. The interview took place Feb. 19, 2026.
Hello, and welcome to the Duvakitug IBD Ph2b Maintenance Topline Results Conference Call. My name is Alex, and I'll be coordinating today's call. [Operator Instructions] I'll now hand it over to Chris ...
You can watch the full Wild Card interview here. Can't see the clip above? Watch it on YouTube. Melinda French Gates on Tuesday said that her ex-husband, Bill Gates, needs to answer for the behavior ...
The Justice Department has released millions of pages of records related to its investigation into Jeffrey Epstein. Deputy Attorney General Todd Blanche announced Friday that the department's ...
The Pittsburgh Steelers are targeting two younger offensive line coaches, in addition to reportedly hiring veteran coach James Campen to lead their offensive line. The Steelers have requested to ...
The Seattle Seahawks emerged as the top dog in the NFL's toughest division, captured the No. 1 seed in a stacked NFC and breezed past both the San Francisco 49ers and Los Angeles Rams in front of ...
Having named Robert Saleh as their new head coach, the Titans have moved on to filling their coordinator positions. According to Tom Pelissero of NFL Network, the Titans plan to interview former ...
Dec 21, 2025; Detroit, Michigan, USA; Fans look on during the game between Detroit Lions and Pittsburgh Steelers at Ford Field. Mandatory Credit: Lon Horwedel-Imagn Images The Pittsburgh Steelers are ...
PITTSBURGH -- The Pittsburgh Steelers are conducting their first in-person head coach interview, only the candidate they're bringing in is very familiar with the facility. The Steelers' first ...
The Detroit Lions have added another impressive name to their offensive coordinator interviews list. Giants interim head coach Mike Kafka is interviewing for the Bucs OC job on Tuesday and the Lions ...
Welcome to the Immuneering conference call to discuss the positive 12-month overall survival update from the company's ongoing Phase IIa trial of atebemetinib in first-line pancreatic cancer patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results